This new paper in Nature strongly confirms that the therapeutic options in Covid should be directed at CCR1 and CCR5 receptor inhibition. This confirms strongly Dr Patterson’s work, and it actually sets his paper up very nicely. That this paper came before his in publication will add a lot of weight to his work. This is another break for us. Good post, really people?

Read More: https://investorshangout.com/post/view?id=580...z6Qadg2H9H
__________________________________________

Chua's et al. paper in Nature was pre-published in Yale on May 5. Dr. Patterson's was pre-published by Yale on May 2, over 8 weeks ago. The difference between them is that Chua's paper is a standard scientific analysis without any specific clinical application to the unfolding crisis. BP's paper is a path-breaking scientific discovery confirmed by a dramatic clinical experience and evidence of the healing powers of leronlimab which had saved four terminally ill patients in Montefiori. Yet , we have no idea when if ever it's going to published by one of the systemic medical journals which are also a part of the systemic corruption.